1-4 of 4
Akash Nahar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Articles

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Clinical Trials & Observations
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A. Johnson ...
Blood (3 October 2019) 134 (14): 1144–1153.
DOI: https://doi.org/10.1182/blood.2019000324
Published: 2019
Includes: Supplemental data
Journal Articles

Two-Year Follow-up of Keynote-087 Study: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma

Pier Luigi Zinzani, MD, Robert W. Chen, MD, Hun Ju Lee, MD, Philippe Armand, MD PhD, Nathalie A Johnson, MD PhD ...
Blood (29 November 2018) 132 (Supplement 1): 2900.
DOI: https://doi.org/10.1182/blood-2018-99-117045
Published: 2018
Journal Articles

Pembrolizumab Antitumor Activity in Relapsed/Refractory Classical Hodgkin Lymphoma in Keynote-087: Revised Response Criteria for Malignant Lymphoma 2007 Criteria Versus Lugano 2014 Classification

Craig H. Moskowitz, MD, Robert W. Chen, MD, Philippe Armand, MD PhD, Pier Luigi Zinzani, MD, Theodoros P. Vassilakopoulos, MD PhD ...
Blood (7 December 2017) 130 (Supplement 1): 4085.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4085.4085
Published: 2017
Journal Articles

Plasma Homocysteine Levels, Methelene TetraHydroFolate Reductase (MTHFR) Polymorphism, and the Risk of Thromboembolism in Children: A Single Institution Experience

Akash Nahar, MD, Yaddanapudi Ravindranath, MBBS, Jeanne M. Lusher, MD, Meera B. Chitlur, MD, Mary Jane Frey ...
Blood (16 November 2008) 112 (11): 5351.
DOI: https://doi.org/10.1182/blood.V112.11.5351.5351
Published: 2008